Actively Recruiting
Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
Led by New England College of Optometry · Updated on 2026-05-11
12
Participants Needed
1
Research Sites
43 weeks
Total Duration
On this page
Sponsors
N
New England College of Optometry
Lead Sponsor
H
H. Eric Cushing Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Central vision loss from macular degeneration creates blind spots that impair reading, face recognition, and navigation. Individuals must learn to use peripheral vision, requiring retraining of eye movements. Our preliminary research using high-speed eye tracking demonstrated that people with larger scotomas have impaired eye movement control, and that single-session visual feedback training showed limited immediate benefit, though combining feedback types showed promise. This study will evaluate whether extended binocular training (5 weekly sessions) with multimodal feedback improves eye movement control in 8-15 participants with bilateral central vision loss. Unlike conventional monocular rehabilitation systems, our approach trains both eyes simultaneously using real-time visual and auditory feedback during saccadic and smooth pursuit tasks. Participants will receive gaze-contingent scotoma awareness feedback, preferred retinal locus feedback, and auditory cues while performing eye tracking exercises. Primary outcomes include saccadic accuracy (latency, landing error, amplitude) and smooth pursuit parameters (gain, tracking accuracy). Secondary outcomes include contrast sensitivity and self-reported visual function. Success could establish an evidence base for accessible home-based training using virtual reality technology, potentially benefiting millions with macular degeneration.
CONDITIONS
Official Title
Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Bilateral central scotomas confirmed by computerized tangent screen
- Visual acuity between 20/60 and 20/200 (0.5 - 1.00 logMAR) in either eye
- Stable central vision loss with no change in visual acuity greater than 0.2 logMAR in the past 6 months
- Age 14 years or older with a diagnosis of macular disease
- Normal cognitive function with Mini-Mental State Examination score of 24 or higher
- Ability to provide informed consent and complete study visits
- No major hearing loss
- Fluent in English
You will not qualify if you...
- Unstable ocular disease, such as ongoing treatments or injections
- Peripheral vision loss less than 40 degrees
- Conditions affecting eye movement control independent of central vision loss
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
New England College of Optometry
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
N
Nicole C Ross, OD
CONTACT
C
Cecilia Idman-Rait, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here